Core Viewpoint - Intuitive Surgical is set to report earnings, with expectations of a gain of 2.02 billion in revenue, while the Whisper number suggests a gain of 3.03 in 2017 to 6.64 in 2024 and 7.65 in 2025 [3]. - The current price-to-earnings (P/E) ratio stands at 75, which is 3.1 times that of the S&P 500 [3]. Technical Analysis - The stock is trading approximately 4.4% below its 52-week high and just below its 50-day moving average [4]. - The stock is close to its all-time high of just under 500, indicating potential volatility following the earnings report [4]. Company Overview - Intuitive Surgical, Inc. specializes in developing, manufacturing, and marketing products that enhance minimally invasive care, including the da Vinci Surgical System and Ion endoluminal system [5][6]. - The company provides a range of services, including installation, repair, maintenance, and technical support, alongside integrated digital capabilities for performance enhancement [6]. - Established in 1995 and headquartered in Sunnyvale, California, the company also collaborates with FluoGuide A/S for head and neck cancer treatments [6].
Earnings Preview: What To Expect From Intuitive Surgical